Literature DB >> 30827155

Discovery of CGRP in relation to migraine.

Lars Edvinsson1, Peter J Goadsby2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30827155     DOI： 10.1177/0333102418779544

Source DB:  PubMed          Journal:  Cephalalgia        ISSN： 0333-1024            Impact factor:   6.292


× No keyword cloud information.
  8 in total

1.  Spotlight on headache.

Authors:  Richard B Lipton
Journal:  Neurol Clin Pract       Date:  2019-06

2.  Delta opioid receptors in Nav1.8 expressing peripheral neurons partially regulate the effect of delta agonist in models of migraine and opioid-induced hyperalgesia.

Authors:  Zachariah Bertels; Isaac J Dripps; Pal Shah; Laura S Moye; Alycia F Tipton; Kendra Siegersma; Amynah A Pradhan
Journal:  Neurobiol Pain       Date:  2022-07-11

3.  Delta opioid receptor regulation of calcitonin gene-related peptide dynamics in the trigeminal complex.

Authors:  Laura S Moye; Kendra Siegersma; Isaac Dripps; Wiktor Witkowski; Elizaveta Mangutov; Dong Wang; Grégory Scherrer; Amynah A Pradhan
Journal:  Pain       Date:  2021-08-01       Impact factor: 7.926

4.  Meningeal CGRP-Prolactin Interaction Evokes Female-Specific Migraine Behavior.

Authors:  Amanda Avona; Bianca N Mason; Carolina Burgos-Vega; Anahit H Hovhannisyan; Sergei N Belugin; Jennifer Mecklenburg; Vincent Goffin; Naureen Wajahat; Theodore J Price; Armen N Akopian; Gregory Dussor
Journal:  Ann Neurol       Date:  2021-04-22       Impact factor: 11.274

5.  TRESK K+ Channel Activity Regulates Trigeminal Nociception and Headache.

Authors:  Zhaohua Guo; Chang-Shen Qiu; Xinghua Jiang; Jintao Zhang; Fengxian Li; Qin Liu; Ajay Dhaka; Yu-Qing Cao
Journal:  eNeuro       Date:  2019-07-29

6.  The neuropeptide landscape of human prefrontal cortex.

Authors:  Wen Zhong; Swapnali Barde; Nicholas Mitsios; Csaba Adori; Per Oksvold; Kalle von Feilitzen; Liam O'Leary; László Csiba; Tibor Hortobágyi; Péter Szocsics; Naguib Mechawar; Zsófia Maglóczky; Éva Renner; Miklós Palkovits; Mathias Uhlén; Jan Mulder; Tomas Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-10       Impact factor: 12.779

7.  Impact on monthly migraine days of discontinuing anti-CGRP antibodies after one year of treatment - a real-life cohort study.

Authors:  Andreas R Gantenbein; Reto Agosti; Claudio Gobbi; Dominique Flügel; Christoph J Schankin; Dragana Viceic; Chiara Zecca; Heiko Pohl
Journal:  Cephalalgia       Date:  2021-05-17       Impact factor: 6.292

8.  Patients with episodic migraine show increased T2 values of the trapezius muscles - an investigation by quantitative high-resolution magnetic resonance imaging.

Authors:  Nico Sollmann; Paul Schandelmaier; Dominik Weidlich; Corinna Börner; Giada Urban; Magdalena Lang; Claus Zimmer; Dimitrios C Karampinos; Mirjam N Landgraf; Florian Heinen; Thomas Baum; Michaela V Bonfert
Journal:  Cephalalgia       Date:  2021-02-20       Impact factor: 6.292
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.